Skip to product information

Indiana University Review and Interpretation of the ASCO Meeting 2024

Indiana University Review and Interpretation of the ASCO Meeting 2024

Regular price $20.00 USD
Regular price $20.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Indiana University Review and Interpretation of the ASCO Meeting 2024

Indiana University Review and Interpretation of the ASCO Meeting 2024

Regular price $20.00
Regular price $20.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Indiana University Review and Interpretation of the ASCO Meeting 2024

     Include: 3 videos + 13 pdfs, size: 1.16 GB
     Target Audience: hematologists, oncologists
     Information:


    Date & Location: Saturday, July 13, 2024, 6:00 AM – 2:40 PM, Indianapolis Marriott Downtown, Indianapolis, IN

    Target Audience Specialties – Hematology and Oncology, Nursing, Pharmacy
    Overview

    This program will provide the participants with the latest information available as presented at the 2024 American Society of Clinical Oncology (ASCO) meeting. Oncology/Hematology faculty members from the Indiana University School of Medicine will provide participants with analysis of the more clinically applicable presentations at this year’s ASCO meeting.

    Objectives
    At the conclusion of this activity, participants should be able to:
    1. Recall and describe the newest developments in the treatment of breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, head/neck cancer, melanoma, hematological mallignancies.
    2. Integrate multimodality treatment strategies, including radiation therapy, chemotherapy, immunotherapy, and targeted therapy, into the management of patients with cancer.
    3. Based on the most up-to-date treatments described in the learning sessions, apply new knowledge and strategies about therapies of solid tumors and hematological malignancies into their clinical practice.

     

     Topics:
    • Breast Oncology Debate.pdf
    • Breast Oncology.pdf
    • Circulating Tumor DNA in Oncology.pdf
    • FINAL – 2024 ASCO Review Schedule [w kathy miller] 06 13 24.pdf
    • Gastrointestinal Oncology.pdf
    • Genitourinary Oncology.pdf
    • Head and Neck Oncology.pdf
    • Leukemia and Myelodysplastic Syndromes.pdf
    • Lymphoma and Multiple Myeloma.pdf
    • Melanoma.pdf
    • Part 1.mp4
    • Part 2.mp4
    • Part 3.mp4
    • Precision Genomics.pdf
    • Thoracic Oncology Debate.pdf
    • Thoracic Oncology.pdf